Show simple item record

dc.contributor.authorGrimmett, C
dc.contributor.authorHaviland, J
dc.contributor.authorWinter, J
dc.contributor.authorCalman, L
dc.contributor.authorDin, A
dc.contributor.authorRichardson, A
dc.contributor.authorSmith, PWF
dc.contributor.authorFoster, C
dc.date.accessioned2017-08-29T10:18:25Z
dc.date.issued2017-10-01
dc.identifier.citationJournal of cancer survivorship : research and practice, 2017, 11 (5), pp. 634 - 642
dc.identifier.issn1932-2259
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/794
dc.identifier.eissn1932-2267
dc.identifier.doi10.1007/s11764-017-0636-x
dc.description.abstractPURPOSE: There is a growing emphasis on self-management of cancer aftercare. Little is known about patient's self-efficacy (confidence) to manage illness-related problems and how this changes over time. This paper describes the patterns of self-efficacy for managing illness-related problems amongst colorectal cancer patients in the 2 years following diagnosis. METHODS: In this prospective cohort study, questionnaires were administered at baseline (pre-surgery), 3, 9, 15 and 24 months to 872 colorectal cancer patients. Self-efficacy (confidence to manage illness-related problems), anxiety, social support, affect, socio-demographics, physical symptoms and clinical and treatment characteristics were assessed. Group-based trajectory analysis identified trajectories of self-efficacy up to 24 months and predictors. RESULTS: Four trajectories of self-efficacy were identified: group 1 (very confident) 16.0% (95% confidence interval (CI) 10.7-21.3%), group 2 (confident) 45.6% (95% CI 40.3-51.0%), group 3 (moderately confident) 29.5% (95% CI 25.1-33.8%) and group 4 (low confidence) 8.9% (95% CI 6.4-11.4%). Greater deprivation, domestic status, more co-morbidities, worse fatigue and pain, lower positivity and greater negativity were significantly associated with lower self-efficacy. There was an increase in mean scores for self-efficacy over time for the whole sample, but this did not reach the cut-off for minimally important differences. At 2 years, the lowest level of confidence to manage was for symptoms or health problems. CONCLUSION: Around 40% of patients had suboptimal levels of confidence to manage illness-related problems with little change from the time of diagnosis across the four groups. IMPLICATIONS FOR CANCER SURVIVORS: Screening for self-efficacy at diagnosis would enable targeted, early intervention which could in turn enhance health-related quality of life.
dc.formatPrint-Electronic
dc.format.extent634 - 642
dc.languageeng
dc.language.isoeng
dc.publisherSPRINGER
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.subjectHumans
dc.subjectColorectal Neoplasms
dc.subjectAftercare
dc.subjectProspective Studies
dc.subjectSelf Efficacy
dc.subjectTime Factors
dc.subjectQuality of Life
dc.subjectMiddle Aged
dc.subjectSurvivors
dc.subjectFemale
dc.subjectMale
dc.subjectSelf-Management
dc.titleColorectal cancer patient's self-efficacy for managing illness-related problems in the first 2 years after diagnosis, results from the ColoREctal Well-being (CREW) study.
dc.typeJournal Article
dcterms.dateAccepted2017-08-01
rioxxterms.versionofrecord10.1007/s11764-017-0636-x
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by/4.0
rioxxterms.licenseref.startdate2017-10
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfJournal of cancer survivorship : research and practice
pubs.issue5
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Clinical Trials & Statistics Unit
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Clinical Trials & Statistics Unit
pubs.publication-statusPublished
pubs.volume11
pubs.embargo.termsNot known
icr.researchteamClinical Trials & Statistics Unit
dc.contributor.icrauthorHaviland, Joanne


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0